BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9610904)

  • 1. Pitfalls of hCG monitoring in stage I seminoma.
    Wylie JP; Logue JP
    Clin Oncol (R Coll Radiol); 1998; 10(2):131-2. PubMed ID: 9610904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
    Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
    Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters.
    Hartmann M; Pottek T; Bussar-Maatz R; Weissbach L
    Eur Urol; 1997; 31(4):408-13. PubMed ID: 9187899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma.
    Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
    Clin Chem; 2007 Aug; 53(8):1560-1. PubMed ID: 17644799
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?
    Suzuki K; Nakazato H; Kurokawa K; Suzuki T; Suzuki K; Yamanaka H
    Int Urol Nephrol; 1998; 30(5):593-8. PubMed ID: 9934803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients.
    Hoshi S; Suzuki K; Ishidoya S; Ohyama C; Sato M; Namima T; Saito S; Orikasa S
    Int J Urol; 2000 Jun; 7(6):218-23. PubMed ID: 10843453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of seminoma patients with serum markers.
    Hotakainen K; Lempiäinen A; Stenman UH
    Cancer; 2013 Jul; 119(13):2511. PubMed ID: 23584987
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Monitoring of seminoma patients with serum markers.
    Vesprini D; Warde P; Chung P
    Cancer; 2013 Jul; 119(13):2511-2. PubMed ID: 23584974
    [No Abstract]   [Full Text] [Related]  

  • 10. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.
    Ferraro S; Trevisiol C; Gion M; Panteghini M
    Clin Chem; 2018 Feb; 64(2):270-278. PubMed ID: 29021329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
    Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
    Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
    Fosså A; Fosså SD
    Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.
    Dieckmann KP; Düe W; Bauer HW
    Int Urol Nephrol; 1989; 21(2):175-84. PubMed ID: 2473044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effectiveness of measurement of serum total human chorionic gonadotropin for diagnosis and management of testicular seminomatous germ cell tumor].
    Takizawa A; Kishida T; Miura T; Ishida H; Noguchi K; Hattori Y; Kubota Y
    Hinyokika Kiyo; 2012 Mar; 58(3):137-42. PubMed ID: 22495041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group.
    Weissbach L; Bussar-Maatz R; Löhrs U; Schubert GE; Mann K; Hartmann M; Dieckmann KP; Fassbinder J
    Eur Urol; 1999 Dec; 36(6):601-8. PubMed ID: 10559615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma.
    Aherne NJ; Small CA; McVey GP; Fitzpatrick DG; Armstrong JG
    World J Surg Oncol; 2008 Jun; 6():68. PubMed ID: 18578862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma.
    Koshida K; Uchibayashi T; Yamamoto H; Hirano K
    Br J Urol; 1996 Jan; 77(1):138-42. PubMed ID: 8653285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human chorionic gonadotropin in patients with pure seminoma.
    Rüther U; Rothe B; Grunert K; Bader H; Sessler R; Nunnensiek C; Rassweiler J; Lüthgens M; Eisenberger F; Jipp P
    Eur Urol; 1994; 26(2):129-33. PubMed ID: 7525293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of thcg assay in the management of testicular cancer--the possibility of a standard assay in testicular cancer as an alternative to FbetahCG assay].
    Takizawa A; Miura T; Kishida T; Fujinami K; Osada Y; Hattori Y; Saito K; Noguchi K; Kubota Y
    Nihon Hinyokika Gakkai Zasshi; 2007 Jan; 98(1):23-9. PubMed ID: 17302291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.